Specific Extracellular Matrix Remodeling Signature of Colon Hepatic Metastases

To identify genes implicated in metastatic colonization of the liver in colorectal cancer, we collected pairs of primary tumors and hepatic metastases before chemotherapy in 13 patients. We compared mRNA expression in the pairs of patients to identify genes deregulated during metastatic evolution. We then validated the identified genes using data obtained by different groups. The 33-gene signature was able to classify 87% of hepatic metastases, 98% of primary tumors, 97% of normal colon mucosa, and 95% of normal liver tissues in six datasets obtained using five different microarray platforms. The identified genes are specific to colon cancer and hepatic metastases since other metastatic locations and hepatic metastases originating from breast cancer were not classified by the signature. Gene Ontology term analysis showed that 50% of the genes are implicated in extracellular matrix remodeling, and more precisely in cell adhesion, extracellular matrix organization and angiogenesis. Because of the high efficiency of the signature to classify colon hepatic metastases, the identified genes represent promising targets to develop new therapies that will specifically affect hepatic metastasis microenvironment.

[1]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[2]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[3]  Kristin L. Sainani,et al.  Comparative Profiling of Primary Colorectal Carcinomas and Liver Metastases Identifies LEF1 as a Prognostic Biomarker , 2011, PloS one.

[4]  D. Tarin,et al.  Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. , 1984, Cancer research.

[5]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[6]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[7]  T. Tsunoda,et al.  Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray. , 2001, Neoplasia.

[8]  W. Hohenberger,et al.  Endothelial cells of human colorectal cancer and healthy colon reveal phenotypic differences in culture , 2007, Laboratory Investigation.

[9]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[10]  A. Hartmann,et al.  Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage , 2004, The Journal of pathology.

[11]  Z. Szallasi,et al.  Evaluation of Microarray Preprocessing Algorithms Based on Concordance with RT-PCR in Clinical Samples , 2009, PloS one.

[12]  Eytan Domany,et al.  Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer , 2009, Proceedings of the National Academy of Sciences.

[13]  Franck Molina,et al.  Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  C. V. van Noorden,et al.  The role of gelatinases in colorectal cancer progression and metastasis. , 2004, Biochimica et biophysica acta.

[15]  H. Parkinson,et al.  A global map of human gene expression , 2010, Nature Biotechnology.

[16]  Zhiyuan Hu,et al.  A compact VEGF signature associated with distant metastases and poor outcomes , 2009, BMC medicine.

[17]  R. Dahiya,et al.  Functional significance of cytochrome P450 1B1 in endometrial carcinogenesis. , 2009, Cancer research.

[18]  T. Yeatman,et al.  Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. , 2010, Gastroenterology.

[19]  I. Fidler,et al.  The pathogenesis of cancer metastasis , 1980, Nature.

[20]  A. Astolfi,et al.  Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. , 2009, Cancer treatment reviews.

[21]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[22]  Michael A. Choti,et al.  Surgical Therapy for Colorectal Metastases to the Liver , 2007, Journal of Gastrointestinal Surgery.

[23]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[24]  C. Sorenson,et al.  CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression. , 2009, Blood.

[25]  D. Tarin,et al.  Clinicopathological observations on metastasis in man studied in patients treated with peritoneovenous shunts. , 1984, British medical journal.

[26]  Zhiyuan Hu,et al.  Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  A. El‐Naggar,et al.  BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells , 2004, Cancer Research.

[28]  M. Takeichi,et al.  Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells. , 1995, Oncogene.

[29]  I. Fidler,et al.  Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.

[30]  A. Stojadinovic,et al.  Evidence‐based medicine in the treatment of peritoneal carcinomatosis: Past, present, and future , 2009, Journal of surgical oncology.

[31]  E. H. Mitchell,et al.  WNT5A Inhibits Metastasis and Alters Splicing of Cd44 in Breast Cancer Cells , 2013, PloS one.

[32]  Raffaele Fronza,et al.  Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. , 2006, Carcinogenesis.

[33]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[34]  G. Murray,et al.  Cytochrome P450 1B1: a novel anticancer therapeutic target. , 2005, Future oncology.

[35]  A. Craig,et al.  Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. , 1994, Cancer research.

[36]  J. Pollard,et al.  Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells , 2011, Nature.

[37]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[38]  S. Rha,et al.  Whole genome analysis for liver metastasis gene signatures in colorectal cancer , 2007, International journal of cancer.

[39]  C. Denis,et al.  Role of von Willebrand factor in tumor metastasis. , 2007, Thrombosis research.

[40]  T. Hickish,et al.  Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  J. Steven Leeder,et al.  Platform dependence of inference on gene-wise and gene-set involvement in human lung development , 2009, BMC Bioinformatics.

[42]  Y. Doki,et al.  The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. , 2007, International journal of oncology.

[43]  T. Bugge,et al.  Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. , 2000, Blood.

[44]  Manuel Hidalgo,et al.  Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  R. Lothe,et al.  Molecular Cancer Gene Expression Profiles of Primary Colorectal Carcinomas, Liver Metastases, and Carcinomatoses , 2022 .

[46]  S. Zucker,et al.  Role of matrix metalloproteinases (MMPs) in colorectal cancer , 2004, Cancer and Metastasis Reviews.

[47]  T. Lumley,et al.  gplots: Various R Programming Tools for Plotting Data , 2015 .

[48]  Hyun Seok Song,et al.  Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells. , 2006, International journal of oncology.

[49]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[50]  Agnes W. O'Brien Seed and Soil , 1905, The Elementary School Teacher.

[51]  M. Bolton,et al.  Squamous cell carcinoma of the colon with an elevated serum squamous cell carcinoma antigen responding to combination chemotherapy. , 2001, Clinical colorectal cancer.

[52]  Hoguen Kim,et al.  Differential Gene Expression Profiles of Metastases in Paired Primary and Metastatic Colorectal Carcinomas , 2008, Oncology.

[53]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.